News & Updates

Show Multimedia Only

Women with past hypertensive pregnancy at greater CV risk

27 May 2025

Blood pressure values and ventricular mass tend to be more elevated among women with previous de novo pre-eclampsia (PE) than those with previous normal pregnancies, according to a study.

Women with past hypertensive pregnancy at greater CV risk

27 May 2025

Uterine atony emerges as leading cause of postpartum haemorrhage

19 May 2025

Postpartum haemorrhage most commonly occurs due to uterine atony, according to a systematic review and meta-analysis. Other causes include genital tract trauma, retained placenta, abnormal placentation, and coagulopathy.

Uterine atony emerges as leading cause of postpartum haemorrhage

19 May 2025

Failed spinal anaesthesia: Reasons, prevention and management

16 May 2025 by

In an interview with MIMS Doctor, Professor Ki-Jinn Chin of the Department of Anesthesiology and Pain Medicine at University of Toronto, Toronto, Ontario, Canada, discusses potential reasons behind failed spinal anaesthesia, suggests possible ways of maximizing its success rate, and offers tips on how to manage complications.

Failed spinal anaesthesia: Reasons, prevention and management

16 May 2025

Elevated TyG index a red flag for adverse metabolic trajectories, pregnancy outcomes in PCOS

13 May 2025

Among patients with polycystic ovary syndrome (PCOS), a high triglyceride-glucose (TyG) index appears to be associated with adverse metabolic trajectories and pregnancy outcomes, according to a study.

Elevated TyG index a red flag for adverse metabolic trajectories, pregnancy outcomes in PCOS

13 May 2025

TAF prophylaxis prevents mother-to-child transmission of HBV

13 May 2025

Treatment with tenofovir alafenamide (TAF) is generally safe and effective for the prevention of hepatitis B virus (HBV) mother-to-child transmission (MTCT), reports a study, noting that the expected 8-week prenatal duration is feasible.

TAF prophylaxis prevents mother-to-child transmission of HBV

13 May 2025

MIRASOL final analysis: MIRV remains superior to chemo for ovarian cancer

13 May 2025 by

In the final overall survival (OS) analysis of the phase III MIRASOL trial, the survival benefit previously reported with the antibody drug conjugate mirvetuximab soravtansine (MIRV) remains superior to investigator’s choice chemotherapy (ICC) for the treatment of folate receptor alpha-positive, platinum-resistant ovarian cancer (FRα+ PROC).

MIRASOL final analysis: MIRV remains superior to chemo for ovarian cancer

13 May 2025

Intrinsic motivations for healthy lifestyle help reduce postpartum weight

12 May 2025 by

Greater intrinsic motivation for engaging in healthy lifestyle behaviours appears to promote long-term postpartum weight reduction and may be a promising target for interventions, suggests a study.

Intrinsic motivations for healthy lifestyle help reduce postpartum weight

12 May 2025

Exercise reduces odds of lower extremity lymphedema in endometrial cancer

10 May 2025

Regular physical activity appears to protect against lower extremity lymphedema in endometrial cancer survivors, as reported in a study.

Exercise reduces odds of lower extremity lymphedema in endometrial cancer

10 May 2025

C-section, painful childbirth tied to severe pain during medical abortion

09 May 2025

History of caesarean delivery and painful childbirth appear to contribute to severe pain during medical abortion beyond known risk factors of nulliparity, dysmenorrhea, and gestational duration, according to a study.

C-section, painful childbirth tied to severe pain during medical abortion

09 May 2025

BRCA-negative ovarian cancer gets PFS gains with pembrolizumab plus olaparib

08 May 2025 by

First-line treatment with chemotherapy plus pembrolizumab followed by maintenance with pembrolizumab plus olaparib, with or without bevacizumab, appears to prolong progression-free survival (PFS) in advanced epithelial ovarian cancer without BRCA 1/2 mutations, according to data from the phase III ENGOT-ov43/GOG-3036/KEYLYNK-001 trial.

BRCA-negative ovarian cancer gets PFS gains with pembrolizumab plus olaparib

08 May 2025

News & Updates

Filter by Specialty:

Specialty:

Women with past hypertensive pregnancy at greater CV risk

Women with past hypertensive pregnancy at greater CV risk

Uterine atony emerges as leading cause of postpartum haemorrhage

Uterine atony emerges as leading cause of postpartum haemorrhage

Failed spinal anaesthesia: Reasons, prevention and management

Failed spinal anaesthesia: Reasons, prevention and management

Elevated TyG index a red flag for adverse metabolic trajectories, pregnancy outcomes in PCOS

Elevated TyG index a red flag for adverse metabolic trajectories, pregnancy outcomes in PCOS

TAF prophylaxis prevents mother-to-child transmission of HBV

TAF prophylaxis prevents mother-to-child transmission of HBV

MIRASOL final analysis: MIRV remains superior to chemo for ovarian cancer

MIRASOL final analysis: MIRV remains superior to chemo for ovarian cancer

Intrinsic motivations for healthy lifestyle help reduce postpartum weight

Intrinsic motivations for healthy lifestyle help reduce postpartum weight

Exercise reduces odds of lower extremity lymphedema in endometrial cancer

Exercise reduces odds of lower extremity lymphedema in endometrial cancer

C-section, painful childbirth tied to severe pain during medical abortion

C-section, painful childbirth tied to severe pain during medical abortion

BRCA-negative ovarian cancer gets PFS gains with pembrolizumab plus olaparib

BRCA-negative ovarian cancer gets PFS gains with pembrolizumab plus olaparib